Question 1

What is the catalog number for LX-2761 intermediate?

Accepted Answer

The catalog number for LX-2761 intermediate is orb1219478.

Question 2

What sizes are available for LX-2761 intermediate?

Accepted Answer

LX-2761 intermediate is available in the following size(s): 500 mg, 1 g, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 200 mg.

Question 3

How many pack sizes does LX-2761 intermediate come in?

Accepted Answer

LX-2761 intermediate is available in 8 different pack sizes.

Question 4

Is LX-2761 intermediate in stock?

Accepted Answer

LX-2761 intermediate is currently made to order / not held in immediate stock. Contact us for lead time.

Question 5

What is LX-2761 intermediate used for?

Accepted Answer

LX-2761 intermediate a chemical compound.

Question 6

Is this product classed as hazardous or restricted for shipping?

Accepted Answer

Some products are subject to special import/export regulations, dangerous goods handling, or licensing requirements. Where this applies, it’s noted on the product page, and any required extra documents or fees will be confirmed with you before dispatch, never added without your consent.

Question 7

Can you help me confirm if this product is right for my specific experiment?

Accepted Answer

Yes, contact us with details of your sample type, species, and intended application, and our specialists will confirm suitability or suggest an alternative from our supplier network if this isn’t the best fit.

Question 8

What is the purity of this recombinant protein?

Accepted Answer

Purity, typically assessed by SDS-PAGE, is listed on the datasheet under quality control data.

LX-2761 intermediate

Product Specifications

CAS Number

Purity

Smiles

Molecular Formula

Molecular Weight

Storage Conditions

Notes

Available Sizes

Frequently Asked Questions

Explore Other Products

SLC6A12 (NM_003044) Human Over-expression Lysate

(3-Bromoimidazo[1,2-a]pyridin-2-yl) methanol

(3-Bromoimidazo[1,2-a]pyridin-2-yl) methanol

FUS Protein Vector (Mouse) (pPB-C-His)

Human SLC35F1 Knockout A549 cell line

Figitumumab (Anti-IGF1R / CD221)